Key result
Combination therapy for hypertension is a rational initial strategy for patients with stage 2 hypertension, proteinuria, diabetes, or renal failure who are unlikely to reach goal blood pressure with monotherapy.
Why the study?
Does combination antihypertensive therapy improve blood pressure control compared to single-drug therapy as initial treatment in patients with hypertension?
Does combination antihypertensive therapy improve blood pressure control compared to single-drug therapy as initial treatment in patients with hypertension?
No takes yet. Share an insight, caveat, or question.
Initial combination therapy for hypertension is a rational and effective strategy for patients with stage 2 hypertension or specific comorbidities, while single-drug therapy remains appropriate for uncomplicated stage 1 hypertension.
Barry J. Materson (2001) conducted a review in Hypertension. Combination therapy vs. Single-drug therapy was evaluated. Combination therapy for hypertension is a rational initial strategy for patients with stage 2 hypertension, proteinuria, diabetes, or renal failure who are unlikely to reach goal blood pressure with monotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: